Page 1

Q1 Quarterly Statement First Quarter of 2021 BAYER BAYER Bayer : successful start to 2021 // Good operational performance - sales and earnings negatively impacted by currency of € 0.9 billion and € 0.3 billion // Group sales at € 12.3 billion ( Fx & p adj . + 2.8 % ) // EBITDA before special items falls 6.2 % to € 4.1 billion due to currency // Strong sales growth at Crop Science ( Fx & p adj . ) in improved market environment // Sales at Pharmaceuticals ( Fx & p adj . ) at prior - year level // Consumer Health ahead of competition with continuous good performance // Net income increases to € 2.1 billion // Core earnings per share € 2.59 ( -3.0 % ) // Outlook for 2021 confirmed Science for a better life